Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

AEZS $1.50 0.1000 +7.14%
AMBI $7.57 0.4700 +6.62%
ARGS $9.39 0.5700 +6.46%
ECYT $7.36 0.3799 +5.44%
ENZN $1.64 0.0800 +5.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OMED $20.29 -1.2900 -5.98%
SNSS $7.49 -0.2900 -3.73%
DRNA $13.78 -0.4500 -3.16%
CNDO $2.10 -0.0600 -2.78%
XLRN $26.87 -0.5800 -2.11%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

October 1, 2014: Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

(FDA.gov) Aug 1, 2014 - Agenda: On October 1, 2014, the committee will discuss, make recommendations, and vote on information regarding the premarket approval application (PMA) for the SONABLATE 450 device sponsored by SonaCare Medical, LLC.
read article 



FDA to Regulate Lab Tests, Especially for Cancer

(Medscape Medical New) Aug 5, 2014 - High-stakes cancer tests are one of the drivers behind the FDA's decision to regulate a category of lab tests that have gotten a free pass from scrutiny for years.
read article (free registration required) 



Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX(R) Prostate Cancer Test with Multiple Clinical Endpoints

(Genomic Health) Aug 6, 2014 - Genomic Health, Inc. today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical endpoints related to disease aggressiveness in men with low- and intermediate-risk prostate cancer.
read corporate press release 



Triple Therapy Revs Up Immune System Against Common Brain Tumor

(Johns Hopkins) Aug 4, 2014 - A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report by scientists at the Johns Hopkins Kimmel Cancer Center.
read press release 



Protein ZEB1 Promotes Breast Tumor Resistance to Radiation Therapy

(MD Anderson) Aug 4, 2014 - One protein called ZEB1 (zinc finger E-box binding homeobox 1) is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a new study.
read press release 



New Hand-Held Device Uses Lasers, Sound Waves for Deeper Melanoma Imaging

(The Optical Society) Aug 6, 2014 - A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis.
read press release 



Exposure to Inflammatory Bowel Disease Drugs Could Increase Leukemia Risk

(AGA) Aug 6, 2014 - Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.
read article 



Laparoscopic vs Open Hepatectomy: Similar Short-term Results

(Medscape Medical New) Aug 4, 2014 - The results of a new study comparing outcomes after laparoscopic or open hepatectomy have shown that these outcomes are similar in the short-term (ie, 30 days).
read article (free registration required) 



Pittsburgh-based Study Offers Hope for Early Esophageal Cancer Test

(Pittsburgh Post-Gazette) Aug 5, 2014 - Having found a way to address the disease’s genetic diversity, Pittsburgh-based researchers published a study Tuesday offering hope of a simple blood test for early detection of lethal esophageal cancer.
read article 



Statins May Protect Against Colon Cancer

(CBS News/HealthDay News) Aug 5, 2014 - Statins, the widely used cholesterol-lowering drugs, may also boost colorectal cancer survival, according to a new U.K. study.
read article 



Nearly 1 in 10 Cancer Survivors Still Smokes

(TIME) Aug 6, 2014 - Nearly one in 10 cancer survivors reports smoking years after their diagnosis, according to a new study from the American Cancer Society.
read article 



Aspirin Could Dramatically Cut Cancer Risk, According to Biggest Study Yet

(The Guardian [UK]) Aug 5, 2014 - An aspirin a day could dramatically cut people's chances of getting and dying from common cancers, according to the most detailed review yet of the cheap drug's ability to stem disease.
read article 



Roche Says Avastin Approved in EU for Type of Ovarian Cancer

(Reuters) Aug 6, 2014 - Roche said on Wednesday that European regulators approved its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy.
read article 



EU Approves Roche’s Avastin for Platinum-resistant Recurrent Ovarian Cancer

(Roche) Aug 6, 2014 - Roche announced today that the European Commission (EU) approved the use of Avastin (bevacizumab) in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin chemotherapy as a treatment for women with recurrent ovarian cancer that is resistant to platinum-containing chemotherapy.
read corporate press release 



Scientific Review Finds Aspirin Significantly Cuts Cancer Rates

(Reuters) Aug 5, 2014 - Taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer, according to a large review of scientific studies.
read article 



Ventana, Quintiles to Offer CDx Testing Services in China for Early Phase Cancer Studies

(GenomeWeb Daily News) Aug 5, 2014 – Roche subsidiary Ventana Medical Systems has signed an agreement with contract research organization Quintiles to offer companion diagnostic testing services to drug developers performing early stage oncology studies in China.
read article (free registration required) 



Hopes Build for New Novartis Heart Failure Drug

(Reuters) Aug 5, 2014 - Expectations are building for a new heart failure drug from Novartis viewed as a likely multibillion-dollar seller, with two surveys of cardiologists published on Tuesday highlighting its potential.
read article 



Study Finds that Hepatitis C in the U.S. Could Become 'Rare' Within 20 Years

(The Week/Speed Reads) Aug 5, 2014 - Researchers using a computer model say that hepatitis C could become "rare" — affecting no more than 1 in 1,500 people — in the United States by 2036.
read article 



Senators Want FDA to Disclose Policy for Naming Biosimilars

(Wall Street Journal/Pharmalot blog) Aug 5, 2014 - One week after the FDA received its first request to approve a biosimilar medicine, a handful of U.S. senators has asked the U.S. Department of Health and Human services when a formal policy will be adopted for naming these medications.
read article (paid subscription required) 



Have Faster FDA Drug Approvals Caused More Safety Problems?

(Wall Street Journal/Pharmalot blog) Aug 5, 2014 - Has a law designed to speed drug approvals resulted in excessive safety issues?
read article (paid subscription required) 



Roche Continues Dealmaking with Acquisition of Santaris

(Financial Times) Aug 4, 2014 - Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group.
read article (free registration required) 



Medicare Cuts Payment for Hospital Admissions as Penalties Rise

(Washington Post/Bloomberg) Aug 4, 2014 - Medicare, the U.S. program for the elderly and disabled, said payments for hospital admissions would fall $756 million next year as penalties stiffen for patients who return too early.
read article (free registration required) 



Feeling as if I Failed the Patient

(New York Times/Well blog) July 31, 2014 - I knew going into this specialty that I would be unsuccessful at curing my patients the majority of the time.
read article 



Idaho Society of Clinical Oncology To Promote Personalized Cancer Therapy

(Yahoo! Finance) Aug 5, 2014 - The Idaho Society of Clinical Oncology (ISCO) had its first Board of Directors retreat in Sun Valley, ID on July 25-26, 2014. ISCO decided to explore the formation of a state wide tumor board concentrating on cutting edge molecular techniques to provide personalized cancer therapy to the patients in in the state of Idaho.
read article 



Why One Cancer Company Has Raised $300 Million 12 Months Without An IPO

(Forbes) Aug 5, 2014 - Juno Therapeutics, already one of the best-funded startups in biotechnology history, just announced that it has raised $134 million in a private placement, meaning it has raised $300 million in less than 12 months.
read article